Generics - Teva Pharmaceutical Industries, GlaxoSmithKline


Popular Filters

Mixed US court decision on ViiV Healthcare’s Epzicom and Trizivir patents


UK pharma giant GlaxoSmithKline and ViiV Healthcare confirmed that the US District Court for the District…

Anti-viralsEpzicomGenericsGlaxoSmithKlineLegalLupinPatentsTeva Pharmaceutical IndustriesTrizivirViiV Healthcare

US Appeals Court reverses 2012 decision on Lovaza, clearing way for generics


Reversing a district court decision last year (The Pharma Letter May 30, 2012), the US Court of Appeals…

AmarinCardio-vascularGenericsGlaxoSmithKlineLegalLovazaNorth AmericaPar PharmaceuticalsPatentsPharmaceuticalTeva Pharmaceutical IndustriesVascepa

Teva/Impax generic Wellbutrin XL 300mg pulled from US market on non-bioequivalence grounds


Following a review of new data, the US Food and Drug Administration says these indicate that Budeprion…

Bupropion HclGenericsGlaxoSmithKlineImpax LaboratoriesNeurologicalNorth AmericaRegulationTeva Pharmaceutical IndustriesWellbutrin XL

Back to top